Emergency Department, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny.
INSERM UMR-S 942, France.
Eur J Emerg Med. 2024 Oct 1;31(5):339-346. doi: 10.1097/MEJ.0000000000001141. Epub 2024 Jun 7.
While the indication for noninvasive ventilation (NIV) in severely hypoxemic patients with acute heart failure (AHF) is often indicated and may improve clinical course, the benefit of early initiation before patient arrival to the emergency department (ED) remains unknown.
This study aimed to assess the impact of early initiation of NIV during emergency medical service (EMS) transportation on outcomes in patients with AHF.
A secondary retrospective analysis of the EAHFE (Epidemiology of AHF in EDs) registry.
Fifty-three Spanish EDs.
Patients with AHF transported by EMS physician-staffed ambulances who were treated with NIV at any time during of their emergency care were included and categorized into two groups based on the place of NIV initiation: prehospital (EMS group) or ED (ED group).
Primary outcome was the composite of in-hospital mortality and 30-day postdischarge death, readmission to hospital or return visit to the ED due to AHF. Secondary outcomes included 30-day all-cause mortality after the index event (ED admission) and the different component of the composite primary endpoint considered individually. Multivariate logistic regressions were employed for analysis.
Out of 2406 patients transported by EMS, 487 received NIV (EMS group: 31%; EMS group: 69%). Mean age was 79 years, 48% were women. The EMS group, characterized by younger age, more coronary artery disease, and less atrial fibrillation, received more prehospital treatments. The adjusted odds ratio (aOR) for composite endpoint was 0.66 (95% CI: 0.42-1.05). The aOR for secondary endpoints were 0.74 (95% CI: 0.38-1.45) for in-hospital mortality, 0.74 (95% CI: 0.40-1.37) for 30-day mortality, 0.70 (95% CI: 0.41-1.21) for 30-day postdischarge ED reconsultation, 0.80 (95% CI: 0.44-1.44) for 30-day postdischarge rehospitalization, and 0.72 (95% CI: 0.25-2.04) for 30-day postdischarge death.
In this ancillary analysis, prehospital initiation of NIV in patients with AHF was not associated with a significant reduction in short-term outcomes. The large confidence intervals, however, may preclude significant conclusion, and all point estimates consistently pointed toward a potential benefit from early NIV initiation.
在严重低氧血症的急性心力衰竭(AHF)患者中,无创通气(NIV)的适应证通常是明确的,并且可能改善临床过程,但在患者到达急诊科(ED)之前早期开始使用 NIV 的益处仍不清楚。
本研究旨在评估在 AHF 患者中,在紧急医疗服务(EMS)转运期间早期开始 NIV 对结局的影响。
对 EAHFE(ED 中 AHF 的流行病学)登记处的二次回顾性分析。
西班牙的 53 个 ED。
接受 AHF 治疗的患者,他们通过配备有 EMS 医生的救护车转运,并且在任何时候都接受 NIV 治疗,这些患者根据 NIV 开始的地点分为两组:院前(EMS 组)或 ED(ED 组)。
主要结局是院内死亡率和 30 天出院后死亡、因 AHF 再次住院或返回 ED 就诊的复合指标。次要结局包括指数事件(ED 入院)后 30 天的全因死亡率以及单独考虑的主要复合终点的不同组成部分。采用多变量逻辑回归进行分析。
在 2406 名接受 EMS 转运的患者中,487 名患者接受了 NIV(EMS 组:31%;ED 组:69%)。平均年龄为 79 岁,48%为女性。EMS 组的特点是年龄较小、更多的冠状动脉疾病和较少的心房颤动,并且接受了更多的院前治疗。复合终点的调整比值比(aOR)为 0.66(95%CI:0.42-1.05)。次要终点的 aOR 为:院内死亡率为 0.74(95%CI:0.38-1.45),30 天死亡率为 0.74(95%CI:0.40-1.37),30 天出院后 ED 再就诊为 0.70(95%CI:0.41-1.21),30 天出院后再住院为 0.80(95%CI:0.44-1.44),30 天出院后死亡为 0.72(95%CI:0.25-2.04)。
在这项辅助分析中,在 AHF 患者中院前开始 NIV 并没有显著降低短期结局。然而,较大的置信区间可能排除了显著的结论,所有的点估计都一致指向早期开始 NIV 的潜在益处。